Herantis Pharma’s Annual Report 2015 published

Herantis Pharma’s Annual Report 2015 published

Herantis Pharma Plc
Company release 17 March 2016 at 10:00 am

Herantis Pharma Plc’s Annual Report for the year 2015 has been published today. The Annual Report contains financial statements and the report of the Board of Directors. The Annual Report is available in PDF format in Finnish and English as an appendix to this release and on the company’s web site at http://herantis.com in section Investors – Financial information.

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 246

About Herantis Pharma Plc

Herantis Pharma Plc is a pharmaceutical company specialised in new drug research and development. The company focuses on diseases with an unmet clinical need. These diseases include for example Parkinson’s disease and secondary lymphedema. The shares of Herantis are listed on the First North Finland marketplace run by Nasdaq Helsinki stock exchange.

Distribution:

Nasdaq Helsinki
Main media
www.herantis.com